Sichuan Biokin Unit Gets $250 Mln Milestone Payment From Bristol Myers
Sichuan Biokin Pharmaceutical's unit received a $250 million milestone payment from Bristol Myers Squibb as part of an Iza-bren agreement.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.